Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar details
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- Introduction
-
16 min
1. Psychopharmacology: structural aspects of the brain- Prof. Brian Leonard
-
66 min
2. The nature of chemical neurotransmission- Prof. Brian Leonard
-
28 min
3. Psychotropic drugs- Prof. Brian Leonard
-
26 min
4. Psychopharmacology of anxiety disorders- Prof. Brian Leonard
-
35 min
5. Psychopharmacology of depression- Prof. Brian Leonard
-
48 min
6. Psychopharmacology of mania and schizophrenia- Prof. Brian Leonard
-
45 min
7. The role of stress and immune system in psychiatric disorders- Prof. Brian Leonard
- Introduction to Genetic Investigations of Complex Traits
-
39 min
- Genetics and Pharmacokinetics of Psychotropic Drugs
-
34 min
9. Genetics of phase I enzymes- Prof. Aiming Yu
-
36 min
10. Phase II metabolism- Prof. Ann Daly
- Genetics and Pharmacodynamics of Psychotropic Drugs
-
25 min
-
25 min
-
51 min
13. Pharmacogenetics of antidepressants- Prof. Alessandro Serretti
- Clinical Applications of Psychopharmacogenetics
-
41 min
14. Of genes and drugs: genetic determinants of adverse drug reactions- Dr. Mario Masellis
-
35 min
15. Cocaine and amphetamine addiction genetics- Dr. Gerome Breen
-
29 min
- Archived Lectures *These may not cover the latest advances in the field
-
47 min
-
37 min
18. Genetic determinants of metabolism: clinical applications in psychiatry- Prof. Julia Stingl (formerly Kirchheiner)
-
36 min
-
47 min
20. Genetic polymorphisms influencing response to lithium- Prof. Alessandro Serretti
-
28 min
21. Genetic determinants of antipsychotic-induced weight gain- Prof. Gavin Reynolds
-
59 min
-
50 min
-
37 min
24. Genetic determinants of agranulocytosis- Dr. Michael Dettling
-
52 min
25. Genetic polymorphisms influencing the response of antidepressants- Prof. Alessandro Serretti
Printable Handouts
Navigable Slide Index
- Introduction
- Symptoms of depression
- Noradrenergic pathways in depression
- Serotonergic pathways in normal brain
- Serotonergic pathways in depression
- Desirable drug - effective in all types of depression
- Desirable features of a drug - rapid onset of action
- Desirable features of an antidepressant
- Psychopathology of depression and drugs used
- Amine deficiency hypothesis
- Neurotransmitters involved in depression
- Treatment and adaptive changes
- Classification of european antidepressants
- MAO inhibitors
- Reuptake inhibitors
- Nonselective reuptake inhibitors
- Selective reuptake inhibitors
- Other antidepressants
- Selectivity of transmitter uptake inhibitors
- Cross-talk between the neurotransmitters
- Sites of action of tricyclics on neuron
- Sites of action of MAO inhibitors
- Electroconvulsive shock therapy
Topics Covered
- Noradrenergic pathways in depression
- Serotonergic pathways in normal brain and in depression
- Desirable features of an antidepressant
- Drugs used in the treatment of depression
- Classification of antidepressants
- Tricyclic antidepressants and monoamine
- Oxidase inhibitors: sites of action
- The relationship between pre- and post-synaptic structures
- Electroconvulsive shock therapy
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Leonard, B. (2007, October 1). Psychopharmacology of depression [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 21, 2024, from https://doi.org/10.69645/ZTMM9663.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Brian Leonard has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Psychopharmacology of depression
Published on October 1, 2007
35 min
